1. Home >
  2. M&A >
  3. Merger >
  4. United States >
  5. Massachusetts >
  6. Korro Bio Acquires Korro Bio

M&A Deal Summary

Korro Bio Acquires Korro Bio

On July 14, 2023, Korro Bio acquired life science company Korro Bio

Acquisition Highlights
  • This is Korro Bio’s 1st transaction in the Life Science sector.
  • This is Korro Bio’s 1st transaction in the United States.
  • This is Korro Bio’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2023-07-14
Target Korro Bio
Sector Life Science
Buyer(s) Korro Bio
Deal Type Merger
Advisor(s) TD Securities (Financial)
Latham & Watkins (Legal)

Target

Korro Bio

Cambridge, Massachusetts, United States
Korro Bio RNA editing company focused on the discovery and development of novel genetic medicines. Korro Bio is based in Cambridge, Massachusetts.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Korro Bio

Woburn, Massachusetts, United States
Category Company
Founded 2014
Sector Life Science
Employees92
Revenue 85M USD (2023)
DESCRIPTION

Korro Bio creates a new class of medicines through Progenitor Cell Activation. Korro Bio is a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Korro Bio was founded in 2014 and is based in Woburn, Massachusetts.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Merger M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2023 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal